Pharvaris N.V.
corporate_fare Company Profile
Pharvaris N.V. (NASDAQ:PHVS) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 22 items for PHVS at importance 7 or higher on its 1–10 market-impact scale.
Recent high-impact activity:
- Deucrictibant Phase 3 Data Shows Rapid, Sustained Efficacy for Angioedema, Meeting All Endpoints
- Pharvaris Outlines 2026 Strategic Priorities, Confirms NDA Filing and Key Phase 3 Data Timelines
Financial Snapshot
Insider Transactions
PHVS files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.